Company intelligence / Profile preview

Nova Laboratories

Wigston, Leicestershire, United Kingdomnovalabs.co.uk ↗
Ownership
Private
Employees
~115
Development stage
Commercial
01

Overview

Nova Laboratories is a leading UK-based independent pharmaceutical manufacturer specializing in aseptic processing for both clinical trials and commercial supply. The company has developed its own pipeline of branded medicines targeting niche and rare diseases. It is recognized for innovation in sterile manufacturing technologies including isolator technology, spray drying, and thermal stabilization platforms such as HydRIS®. The company also provides contract services to pharma/biotech clients globally.

Modalities
Small moleculeBiologicMonoclonal antibodyPeptidesPlasmids
Industry
Biotech
02

Drug pipeline

1 asset

hepar-p

2

Beyond the preview

Go deeper on Nova Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nova Laboratories.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call